Celgene and Novartis Pharma Sue Mylan Pharmaceuticals
- April 12, 2011
Celgene and Novartis Pharma files suit against Mylan Pharmaceuticals over six patents related to extended release dexmethylphenidate hydrochloride capsules. 4/1, District of New Jersey, 2:2011cv01882.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.